Incarcerated women face challenges in accessing menstrual hygiene products

NewsGuard 100/100 Score

A new study has shown that among incarcerated women, many have to trade or barter to access menstrual hygiene products. The study, which examines menstrual equity, or the access to menstrual products and safe menstruating environments, in the criminal legal system, is published in the peer-reviewed Journal of Women's Health.

Patricia Kelly, PhD, from Thomas Jefferson University School of Nursing, and coauthors, found that 53.8% of women involved in the criminal legal system received less than five menstrual products at intake/initial processing. They further reported that 29.5% had to trade or barter menstrual hygiene products.

"Almost one-quarter (23.1%) suffered negative health consequences from prolonged use of products because of limited supply," stated the investigators.

As reported in this important study, the lack of access to menstrual products can have negative health consequences."

Susan G. Kornstein, MD, Journal of Women's Health Editor-in-Chief, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA.

Source:
Journal reference:

Darivemula, S., et al. (2023) Menstrual Equity in the Criminal Legal System. Journal of Women's Health. doi.org/10.1089/jwh.2023.0085.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer